Graeber, S.Y.; Balázs, A.; Ziegahn, N.; Rubil, T.; Vitzthum, C.; Piehler, L.; Drescher, M.; Seidel, K.; Rohrbach, A.; Röhmel, J.;
et al. Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis. Int. J. Mol. Sci. 2023, 24, 12365.
https://doi.org/10.3390/ijms241512365
AMA Style
Graeber SY, Balázs A, Ziegahn N, Rubil T, Vitzthum C, Piehler L, Drescher M, Seidel K, Rohrbach A, Röhmel J,
et al. Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis. International Journal of Molecular Sciences. 2023; 24(15):12365.
https://doi.org/10.3390/ijms241512365
Chicago/Turabian Style
Graeber, Simon Y., Anita Balázs, Niklas Ziegahn, Tihomir Rubil, Constanze Vitzthum, Linus Piehler, Marika Drescher, Kathrin Seidel, Alexander Rohrbach, Jobst Röhmel,
and et al. 2023. "Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis" International Journal of Molecular Sciences 24, no. 15: 12365.
https://doi.org/10.3390/ijms241512365
APA Style
Graeber, S. Y., Balázs, A., Ziegahn, N., Rubil, T., Vitzthum, C., Piehler, L., Drescher, M., Seidel, K., Rohrbach, A., Röhmel, J., Thee, S., Duerr, J., Mall, M. A., & Stahl, M.
(2023). Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis. International Journal of Molecular Sciences, 24(15), 12365.
https://doi.org/10.3390/ijms241512365
